Qiagen alleges that BioMérieux infringes a European patent that protects the company's QuantiFeron interferon-gamma release assay technology for latent TB detection.

Of the 30 companies on the list, 22 firms saw their share prices decline month over month, while eight companies saw their stock prices rise.

The firm's Anti-Measles Virus ELISA 2.0 (IgG) is used with dried blood spot samples to identify infections and determine patients' immune status.

Last week, readers were most interested in a story about Pfizer shuttering the Lucira Health business that it acquired in 2023.

One ACED project is focused on developing biomarkers for the early detection of ovarian cancer, with the goal of commercializing any resulting tests.

The company has received certification under Europe's In Vitro Diagnostic Regulation for a number of tests recently.

The paper-based card separates plasma from whole-blood samples, allowing them to be used for HIV viral load testing.

NEW YORK – After acquiring Lucira Health in a bankruptcy auction in 2023, Pfizer has decided to shut down the business, a Pfizer spokesperson told GenomeWeb.

The company will use the lab to run its PromarkerD proteomic blood test for identifying individuals at risk of diabetes-related chronic kidney disease.

The firm's Qlucore Diagnostics 1.0 for BCP-ALL software is used to aid the diagnosis and treatment of B-cell precursor acute lymphoblastic leukemia.

The group recently published a case-control study showing high sensitivity and specificity, with little drop in early-stage disease, compared to late-stage cancer.